Evidence map›Paper›PMID 42825271›Full record

ArticleBMJ neurology open2026

Epidemiology of progressive cerebellar ataxia in South Yorkshire, UK.

Emma Foster, Priya Darshni Shanmugarajah, Suzanna Duty, Ewelina Hogg, Marios Hadjivassiliou

Abstract read
In one paragraph

Article in BMJ neurology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Emma FosterAcademic Department of Neurosciences, Sheffield Teaching Hospitals NHS Trust and University of Sheffield, Sheffield, UK.ORCID https://orcid.org/0000-0002-2081-1973
Priya Darshni ShanmugarajahAcademic Department of Neurosciences, Sheffield Teaching Hospitals NHS Trust and University of Sheffield, Sheffield, UK.
Suzanna DutyAcademic Department of Neurosciences, Sheffield Teaching Hospitals NHS Trust and University of Sheffield, Sheffield, UK.
Ewelina HoggAcademic Department of Neurosciences, Sheffield Teaching Hospitals NHS Trust and University of Sheffield, Sheffield, UK.
Marios HadjivassiliouAcademic Department of Neurosciences, Sheffield Teaching Hospitals NHS Trust and University of Sheffield, Sheffield, UK.ORCID https://orcid.org/0000-0003-2542-8954

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cerebellar ataxias are a heterogeneous group of rare neurological disorders characterised by progressive gait instability, limb incoordination, speech and oculomotor impairment. UK prevalence estimates remain rather limited, with the most widely cited population-based study performed in South East Wales over two decades ago. The objective is to estimate the current prevalence of progressive cerebellar ataxia within South Yorkshire using a comprehensive NHS (National Health Service) tertiary ataxia service database and to compare findings with previously published UK data. Methods: A retrospective epidemiological analysis was undertaken using the Sheffield Ataxia Centre NHS clinical database. All alive patients aged over 18 years living in South Yorkshire with confirmed progressive cerebellar ataxia under active or historical follow-up were included, excluding static and structural ataxias where appropriate. Population sizes within South Yorkshire were derived from the 2024 Office for National Statistics (ONS) mid-year population estimates for everyone aged over 18 years and over 65 years. Results: A total of 1204 individuals with progressive cerebellar ataxia were identified as resident in South Yorkshire, corresponding to a frequency prevalence of approximately 106 per 100 000 population (1:942). Prevalence varied by local authority, ranging from 1:647 in Sheffield to 1:1677 in Doncaster. Conclusions: The prevalence of progressive cerebellar ataxia in South Yorkshire is substantially higher than previously reported UK figures, likely reflecting improvements in diagnostic capability, service centralisation and recognition of immune-mediated and new novel genetic ataxias. These figures have important implications for service planning and resource allocation within the NHS.

Indexed as

CEREBELLAR ATAXIACEREBELLAR DISEASENEUROMUSCULAR

Identifiers

PMID42825271
PMCPMC13630031

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.